CURAVAC EUROPE (Public limited company)
CURAVAC EUROPE is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0479.403.989. It was founded on 28-01-2003. Its registered office is in Rixensart. Its main activity is: Manufacture of basic pharmaceutical products and pharmaceutical preparations. Its annual accounts for 2025 report equity of € 1 146 834 and a loss of € 111 132. Addrly gives it a financial health grade of B, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 4 financial years.
Information last updated on 09-10-2026.
Company information
Key figures of CURAVAC EUROPE
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
Profit / lossiWhat the period earned after taxes. A negative amount is a loss. | € -111 132+57 % | € -257 915-1 506 % | € -16 060+83 % | € -92 822 |
EquityiWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company. | € 1 146 834+1 % | € 1 133 250+190 % | € 391 165-4 % | € 407 225 |
Total assetsiEverything the company owns. Equal to total equity and liabilities, which says how it is financed. | € 2 352 164-7 % | € 2 526 379+14 % | € 2 211 775+4 % | € 2 132 516 |
Gross marginiSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else. | € -72 254+52 % | € -150 346 | € 43 389-34 % | € 65 832 |
Employees (FTE)iAverage number of workers over the period, in full-time equivalents. | - | - | - | - |
Financial estimate
- 2 Board links
Similar companies
Other companies in the same activity in Rixensart.
| Company | Town |
|---|---|
| GlaxoSmithKline Biologicals | 1330 Rixensart |
| HOME CONCEPT | 1330 Rixensart |
| AUDIF | 1330 Rixensart |
Frequently asked questions
Is CURAVAC EUROPE still active? Yes. The Crossroads Bank for Enterprises lists CURAVAC EUROPE as active.
What is the VAT number of CURAVAC EUROPE? The VAT number of CURAVAC EUROPE is BE 0479.403.989.
When was CURAVAC EUROPE founded? CURAVAC EUROPE was founded on 28-01-2003.
What is the address of CURAVAC EUROPE? The current registered office of CURAVAC EUROPE is Avenue de Villefranche 80, 1330 Rixensart.
When did CURAVAC EUROPE last file annual accounts? The latest annual accounts of CURAVAC EUROPE were filed on 17-07-2026.
Does CURAVAC EUROPE file its annual accounts on time? Yes. CURAVAC EUROPE filed its annual accounts within the legal deadline for each of its last 4 financial years.
Is CURAVAC EUROPE financially healthy? Addrly gives CURAVAC EUROPE a financial health grade of B, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.
Is CURAVAC EUROPE profitable? The annual accounts of CURAVAC EUROPE for 2025 show a loss of € 111 132.
What is the equity of CURAVAC EUROPE? The equity of CURAVAC EUROPE was € 1 146 834 at the close of the 2025 financial year.
Who are the directors of CURAVAC EUROPE? The annual accounts of CURAVAC EUROPE record 6 mandates. The names, roles and dates are visible with a free account.
Can CURAVAC EUROPE receive Peppol e-invoices? Yes. CURAVAC EUROPE is registered on the Peppol network and can receive structured electronic invoices.
What does CURAVAC EUROPE do? The main activity of CURAVAC EUROPE is: Manufacture of basic pharmaceutical products and pharmaceutical preparations.